MedTrace Logo

Prevalence of Sleep Apnea and Atrial Fibrillation

NCT05155813 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-06-07

No results posted yet for this study

Summary

The investigators will screen consecutive patients presenting to the atrial fibrillation clinic for sleep apnea using a FDA-approved home sleep testing device, WatchPAT to determine prevalence of sleep apnea in a clinic-based sample.

Conditions

Interventions

DEVICE

WatchPAT

FDA-approved portable home sleep testing device worn on the wrist.

Sponsors & Collaborators

  • Itamar-Medical, Israel

    collaborator INDUSTRY

  • Brigham and Women's Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-12-31
Completion
2023-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05155813 on ClinicalTrials.gov